Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
62 GBX | +0.81% | +0.81% | +19.23% |
Mar. 19 | Tissue Regenix annual loss narrows sharply as revenue jumps | AN |
Mar. 19 | Earnings Flash (TRX.L) TISSUE REGENIX GROUP Reports FY23 Revenue $29.5M | MT |
Sales 2024 * | 27.11M 33.9M | Sales 2025 * | 31.03M 38.8M | Capitalization | 43.3M 54.14M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.69 x |
Net Debt 2024 * | 2.62M 3.28M | Net Debt 2025 * | 3.84M 4.8M | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
-366
x | P/E ratio 2025 * |
147
x | Employees | 82 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.25% |
1 day | +0.81% | ||
1 week | +0.81% | ||
Current month | -0.80% | ||
1 month | -0.80% | ||
3 months | +8.77% | ||
6 months | +12.73% | ||
Current year | +19.23% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
Kirsten Lund
DFI | Director of Finance/CFO | - | 09-12-31 |
David Cocke
DFI | Director of Finance/CFO | 58 | 21-01-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Phillips
BRD | Director/Board Member | 63 | 21-01-04 |
George Phillips
BRD | Director/Board Member | 64 | 21-01-04 |
Daniel Lee
CEO | Chief Executive Officer | 63 | 18-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 62 | +0.81% | 81 |
24-04-25 | 61.5 | +2.16% | 53,466 |
24-04-24 | 60.2 | -2.11% | 47,682 |
24-04-23 | 61.5 | 0.00% | 19,970 |
24-04-22 | 61.5 | 0.00% | 15,013 |
Delayed Quote London S.E., April 26, 2024 at 03:00 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.23% | 54.11M | |
+3.41% | 32.18B | |
+14.14% | 7.33B | |
+21.16% | 3.83B | |
-14.26% | 3.23B | |
-27.90% | 1.25B | |
-34.43% | 1.12B | |
+2.01% | 912M | |
-24.21% | 856M | |
-38.47% | 859M |
- Stock Market
- Equities
- TRX Stock